Last update :
21/10/2020
Summary lists   Summary lists  

This page permits the cross-consultation of the stability information.

Stability in solutions
Factors which affect stability
Incompatibilities
Route of administration
Route of administration
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y -      Pdf
Compound Container Solvent Concentration Temperature Storage Length of time References
Injection Cefuroxime sodium AT-Closed vial® Sodium chloride 0,9% 10 mg/ml -20°C Protect from light
365 Day
1972
Injection Cefuroxime sodium AT-Closed vial® Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
16 Hour
1972
Injection Cefuroxime sodium AT-Closed vial® Sodium chloride 0,9% 10 mg/ml 5°C Protect from light
21 Day
1972
Injection Midazolam hydrochloride AT-Closed vial® Sodium chloride 0,9% 1 mg/ml -20°C Protect from light
365 Day
3989
Injection Midazolam hydrochloride AT-Closed vial® Sodium chloride 0,9% 1 mg/ml -20°C Not specified
365 Day
4201
Injection Midazolam hydrochloride AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
365 Day
4201
Injection Midazolam hydrochloride AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 23-25°C Not specified
90 Day
4201
Injection Midazolam hydrochloride AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 5°C Protect from light
365 Day
3989
Injection Norepinephrine bitartrate AT-Closed vial® Sodium chloride 0,9% 0.2 mg/ml -20°C Protect from light
365 Day
3989
Injection Norepinephrine bitartrate AT-Closed vial® Sodium chloride 0,9% 0.2 mg/ml 5°C Protect from light
365 Day
3989

  Mentions Légales